Trade Mark Journal No.2026/006 6 February 2026
WO0000001877696 (9,16,35,38,41,42,44)
Office of origin: United States of America
Date of International Registration:16 May 2025
Date of designation in the UK:
16 May 2025
International priority date claimed: 17 December 2024
(United States of America)
(98908360)
- Class 9
- Downloadable children's books; downloadable children's booklets; downloadable children's activity books; downloadable newsletters; downloadable computer software games.
- Class 16
- Printed children's books; printed children's booklets; printed activity books; printed newsletters in the field of endocrine diseases and disorders.
- Class 35
- Administering a patient support program to coordinate access to medicines; administering a patient support program to provide pharmaceutical co-pay assistance; administering a patient support program to provide general education and support and information about available resources for patients, caregivers and healthcare providers; administering a patient support program to provide and assist with insurance coverage and reimbursement information; promoting awareness of congenital adrenal hyperplasia including via a public platform to discuss congenital adrenal hyperplasia and coping strategies; promoting awareness of adrenal insufficiency including via a public platform to discuss adrenal insufficiency and coping strategies; promoting awareness of endocrine diseases and disorders including via a public platform to discuss endocrine diseases and disorders and coping strategies; promoting the interests of people who have congenital adrenal hyperplasia and their families and health care providers by means of public advocacy; promoting the interests of people who have adrenal insufficiency and their families and health care providers by means of public advocacy; promoting the interests of people who have endocrine diseases and disorders and their families and health care providers by means of public advocacy; maintaining a registry of patients with congenital adrenal hyperplasia; maintaining a registry of patients with adrenal insufficiency; maintaining a registry of patients with endocrine diseases and disorders; updating and maintenance of information in registries, namely, administering a patient registry for patients with congenital adrenal hyperplasia; updating and maintenance of information in registries, namely, administering a patient registry for patients with adrenal insufficiency; updating and maintenance of information in registries, namely, administering a patient registry for patients with endocrine diseases and disorders.
- Class 38
- Providing an online forum in the field of health and pharmaceuticals.
- Class 41
- Educational services; providing mentorship programs in the field of health and pharmaceuticals; providing an in-person health forum for users to participate in discussions in the field of congenital adrenal hyperplasia; providing an in-person health forum for users to participate in discussions in the field of adrenal insufficiency; providing an in-person health forum for users to participate in discussions in the field of endocrine diseases and disorders.
- Class 42
- Providing information about medical research; providing medical research information in the field of pharmaceuticals and congenital adrenal hyperplasia; providing medical research information in the field of pharmaceuticals and adrenal insufficiency; providing medical research information in the field of pharmaceuticals and endocrine diseases and disorders; providing software services enabling the creation of an online community for users for the purpose of participating in discussions in the fields of health, pharmaceuticals, and coping strategies.
- Class 44
- Providing medical information; providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia; providing medical information to patients, medical professionals, and insurance companies in the field of adrenal insufficiency; providing medical information to patients, medical professionals, and insurance companies in the field of endocrine diseases and disorders; online information services, namely, providing medical information in the field of congenital adrenal hyperplasia; online information services, namely, providing medical information in the field of adrenal insufficiency; online information services, namely, providing medical information in the field of endocrine diseases and disorders.
Neurocrine Biosciences, Inc.
Representative: Mishcon De Reya LLP, Africa House, 70 Kingsway London WC2B 6AH UNITED KINGDOM